Gigantomastia and Macroprolactinemia Responding to Cabergoline Treatment: A Case Report and Minireview of the Literature
Background. Macroprolactinemia is defined as predominance of high molecular weight prolactin forms in the circulation. Although macroprolactin is considered as a biologically inactive molecule, some authorities suggest treatment in symptomatic cases. Gigantomastia is defined as excess breast tissue...
Saved in:
Main Authors: | Fatma Dilek Dellal, Didem Ozdemir, Cevdet Aydin, Gulfem Kaya, Reyhan Ersoy, Bekir Cakir |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Case Reports in Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2016/3576024 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Macroprolactinemia in a Patient with Invasive Macroprolactinoma: A Case Report and Minireview
by: Atanaska Elenkova, et al.
Published: (2013-01-01) -
Macroprolactinemia: Diagnostic, Clinical, and Pathogenic Significance
by: Akira Shimatsu, et al.
Published: (2012-01-01) -
Broken Instrument Removal Methods with a Minireview of the Literature
by: Mohsen Aminsobhani, et al.
Published: (2024-01-01) -
Primary Thyroid Disorders in Patients with Endogenous Hypercortisolism: An Observational Study
by: Eda Demir Onal, et al.
Published: (2014-01-01) -
The Influence of Concurrent Autoimmune Thyroiditis on the Cardiometabolic Consequences of Cabergoline in Postmenopausal Women
by: Robert Krysiak, et al.
Published: (2025-01-01)